{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Clinical trial", "Osteoarthritis", "Ozonated oil", "Ozone therapy", "Topical route"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "33706065", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "04"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "04"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2021", "Month": "03", "Day": "05"}], "ELocationID": ["10.1016/j.ctcp.2021.101351", "S1744-3881(21)00050-5"], "Journal": {"ISSN": "1873-6947", "JournalIssue": {"Volume": "43", "PubDate": {"Year": "2021", "Month": "May"}}, "Title": "Complementary therapies in clinical practice", "ISOAbbreviation": "Complement Ther Clin Pract"}, "ArticleTitle": "Effectiveness of topical ozonated oil in severe osteoarthritis: A randomised, triple-blinded, placebo-controlled study.", "Pagination": {"StartPage": "101351", "MedlinePgn": "101351"}, "Abstract": {"AbstractText": ["Osteoarthritis is highly prevalent and a common locomotory disorder in the elderly. The treatments aim improves the quality of life. We aimed to evaluate the effectiveness of topical ozonated oil in relieving pain in patients with osteoarthritis.", "A placebo-controlled, triple-blind, randomised controlled trial including osteoarthritis patients older than 50 years.", "Eighty patients were randomly divided into two groups: treatment (ozonated oil) and placebo (non-ozonated oil). The oils were used twice a day for 60 days. Evaluations were performed using WOMAC (Western Ontario and McMaster Universities) and VAS (visual analogue scale) and laboratory analysis.", "Pain relief was observed in all groups except in the placebo group where patients are diagnosed with severe osteoarthritis (degree 4) (p-value treatment and placebo group: 0.021 and 0.345, respectively).", "For the first time, the pain relief in patients with severe osteoarthritis was demonstrated by the use of topical ozonated oil."], "CopyrightInformation": "Copyright \u00a9 2021 Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Program in Human Aging, University of Passo Fundo, Passo Fundo, Rio Grande do Sul, Brazil. Electronic address: anapaulasordianzolin@gmail.com."}], "LastName": "Anzolin", "ForeName": "Ana Paula", "Initials": "AP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Hospital of Passo Fundo, Passo Fundo, Rio Grande do Sul, Brazil."}], "LastName": "Collares", "ForeName": "Diego da Silva", "Initials": "DDS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Hospital of Passo Fundo, Passo Fundo, Rio Grande do Sul, Brazil."}], "LastName": "Tadeu Dos Santos", "ForeName": "Renato", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Program in Human Aging, University of Passo Fundo, Passo Fundo, Rio Grande do Sul, Brazil."}], "LastName": "Pasqualotti", "ForeName": "Adriano", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Program in Bioexperimentation, University of Passo Fundo, Passo Fundo, Rio Grande do Sul, Brazil."}], "LastName": "Rossato-Grando", "ForeName": "Luciana Grazziotin", "Initials": "LG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Program in Human Aging, University of Passo Fundo, Passo Fundo, Rio Grande do Sul, Brazil; College of Pharmacy, University of Passo Fundo, Passo Fundo, Rio Grande do Sul, Brazil. Electronic address: charise@upf.br."}], "LastName": "Bertol", "ForeName": "Charise Dallazem", "Initials": "CD"}], "PublicationTypeList": ["Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Complement Ther Clin Pract", "NlmUniqueID": "101225531", "ISSNLinking": "1744-3881"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Ontario"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Osteoarthritis, Knee"}, {"QualifierName": [], "DescriptorName": "Pain Measurement"}, {"QualifierName": [], "DescriptorName": "Quality of Life"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2020", "Month": "11", "Day": "2"}, {"Year": "2021", "Month": "2", "Day": "9"}, {"Year": "2021", "Month": "2", "Day": "27"}, {"Year": "2021", "Month": "3", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "11", "Hour": "20", "Minute": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33706065", "10.1016/j.ctcp.2021.101351", "S1744-3881(21)00050-5"]}}], "PubmedBookArticle": []}